What is common to the diseases given in the box?
Type 1 diabetes, Graves' disease, Multiple sclerosis, Psoriasis, Rheumatoid arthritis, Myasthenia gravis, and Systemic lupus erythematosus |
1. | They are congenital diseases |
2. | They are caused by multiple mutational events |
3. | They result from the loss of capability of the immune system to distinguish between self and non-self |
4. | They are completely curable |
An immune process where particles such as bacteria are targeted for destruction by an immune cell known as a phagocyte is called as:
1. | chemotaxis | 2. | opsonization |
3. | cloning | 4. | anergy |
Graft rejection is due to:
1. Innate immune response
2. Humoral immune response
3. Cell-mediated immune response
4. Auto-immune response
All of the following are true regarding inflammation except:
1. | The same sequence of events occurs in response to any injury, whether it be a burn, an infection, or trauma. |
2. | The signs of inflammation are pain, redness, swelling, heat, and possibly loss of function. |
3. | Cytokines, histamine, complement, and other chemical mediators are released. |
4. | Monocytes are the first cells to arrive from the bloodstream at the site of inflammation. |
Some common diseases that are generally considered autoimmune include all the following except:
1. Celiac disease
2. Psoriasis
3. Systemic lupus erythematosus
4. Type II diabetes mellitus
1. | Macrophages | 2. | Mast cells |
3. | Basophils | 4. | Eosinophils |
Which of the following are the reason(s) for Rheumatoid arthritis? Choose the correct option.
i: | The ability to differentiate pathogens or foreign molecules from self-cells increases. |
ii: | Body attacks self cells. |
iii: | More antibodies are produced in the body. |
iv: | The ability to differentiate pathogens or foreign molecules from self-cells is lost. |
1. | i and ii | 2. | ii and iv |
3. | iii and iv | 4. | i and iii |
I: | are caused by hypersensitivity of the immune system to typically harmless substances in the environment. |
II: | involve immunoglobulin E antibodies |